Publication | Closed Access
Sorafenib suppresses radioresistance and synergizes radiotherapy-mediated CD8+ T cell activation to eradicate hepatocellular carcinoma
26
Citations
33
References
2022
Year
Cancer ImmunosurveillanceHepatocellular CarcinomaMedicineImmunologyLiver CancerCell BiologyImmunotherapyOncologyRadiation OncologyTumor Microenvironment
| Year | Citations | |
|---|---|---|
Page 1
Page 1